Cost‐effectiveness of generic pan‐genotypic sofosbuvir/velpatasvir
versus
genotype‐dependent direct‐acting antivirals for hepatitis C treatment
2018 ◽
Vol 33
(12)
◽
pp. 2029-2036
◽
Keyword(s):
Keyword(s):
2018 ◽
Vol 8
◽
pp. S14
◽
Keyword(s):
2017 ◽
Vol 7
◽
pp. S22-S23
Keyword(s):
2018 ◽
Vol 16
(1)
◽
pp. 115-122.e10
◽
Keyword(s):
2016 ◽
Vol 64
(2)
◽
pp. S774-S775
◽
Keyword(s):
Keyword(s):